ADVISORY, May 31, 2007 (PrimeNewswire via COMTEX News Network) --

 What:
 John F. Crowley, President and Chief Executive Officer of Amicus
 Therapeutics (FOLD), will preside over the closing bell to celebrate
 the Company's initial public offering on NASDAQ.

 Where:
 NASDAQ MarketSite - 4 Times Square - 43rd & Broadway - Broadcast Studio

 When:
 Thursday, May 31, 2007 at 4 p.m. ET

 Contact:
 NASDAQ MarketSite:
 Jolene Libretto; 646.441.5220; 347.219.9539
 Jolene.Libretto@NASDAQ.com

Feed Information:

The closing bell is available from 3:50 p.m. to 4:05 p.m. on uplink IA-6 C-band/transponder 17. The downlink frequency is 4040 Vertical; Audio 6.2-6.8. The feed can also be found on Waterfront fiber 1623. If you have any questions, please contact Jolene Libretto at (646) 441-5220.

Radio Feed:

An audio transmission of the closing bell is also available from 3:50 p.m. to 4:05 p.m. on uplink IA6 C band / transponder 24, downlink frequency 4180 horizontal. The feed can be found on Waterfront fiber 1623 as well.

Webcast:

A live Webcast of the NASDAQ Closing Bell will be available at: http://www.nasdaq.com/reference/marketsite_about.stm

Photos:

To obtain a hi-resolution photograph of the Market Close, please go to http://www.nasdaq.com/reference/marketsite_events.stm and click on the market close of your choice.

About Amicus Therapeutics, Inc. (FOLD):

This news release was distributed by PrimeNewswire, www.primenewswire.com

SOURCE: The Nasdaq Stock Market, Inc.

Amicus Therapeutics is a clinical-stage biopharmaceutical company focused on the discovery, development, and commercialization of a new class of small molecule, orally-administered drugs to treat a range of human genetic diseases.

(C) Copyright 2007 PrimeNewswire, Inc. All rights reserved.

News Provided by COMTEX